| Rajesh Chawla, MD | |
|
900 S 1st Ave, Ste C, Arcadia, CA 91006-7527 | |
| (626) 566-2750 | |
| (626) 566-2756 |
| Full Name | Rajesh Chawla |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 36 Years |
| Location | 900 S 1st Ave, Arcadia, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982657763 | NPI | - | NPPES |
| 00A519910 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A51991 (California) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | A51991 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital Of Southern Ca | Arcadia, CA | Hospital |
| Entity Name | Cardiovascular Consultants Of San Gabriel Valley, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205881521 PECOS PAC ID: 7113936006 Enrollment ID: O20060420000727 |
News Archive
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
More than half of men dying of prostate cancer use hospice care - a significant increase over the last two decades - but most wait too long to enroll so they can't take full advantage of the palliative care that could make their deaths easier, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center found.
› Verified 4 days ago
| Entity Name | Foothill Vascular Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194060905 PECOS PAC ID: 2365689759 Enrollment ID: O20130501000573 |
News Archive
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
More than half of men dying of prostate cancer use hospice care - a significant increase over the last two decades - but most wait too long to enroll so they can't take full advantage of the palliative care that could make their deaths easier, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center found.
› Verified 4 days ago
| Entity Name | Valley Vascular Partners, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407393754 PECOS PAC ID: 0941583611 Enrollment ID: O20170203002353 |
News Archive
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
More than half of men dying of prostate cancer use hospice care - a significant increase over the last two decades - but most wait too long to enroll so they can't take full advantage of the palliative care that could make their deaths easier, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center found.
› Verified 4 days ago
| Entity Name | Vascular Intervention Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063959310 PECOS PAC ID: 0547543753 Enrollment ID: O20170214002134 |
News Archive
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
More than half of men dying of prostate cancer use hospice care - a significant increase over the last two decades - but most wait too long to enroll so they can't take full advantage of the palliative care that could make their deaths easier, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center found.
› Verified 4 days ago
| Entity Name | Vascular Interventional Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508363714 PECOS PAC ID: 8426386798 Enrollment ID: O20190823002296 |
News Archive
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
More than half of men dying of prostate cancer use hospice care - a significant increase over the last two decades - but most wait too long to enroll so they can't take full advantage of the palliative care that could make their deaths easier, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center found.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rajesh Chawla, MD 900 S 1st Ave, Ste C, Arcadia, CA 91006-7527 Ph: (626) 566-2750 | Rajesh Chawla, MD 900 S 1st Ave, Ste C, Arcadia, CA 91006-7527 Ph: (626) 566-2750 |
News Archive
The abnormal accumulation of proteins in the brain is a biological marker for Alzheimer's disease, but the ways in which these proteins spread may help explain why the prevalence of Alzheimer's is higher in women than in men.
A team of scientists from the United States has recently revealed how interactions between the SARS-CoV-2 nucleocapsid protein and the double-stranded RNA motifs impart distinct droplet properties that can support multiple viral functions. The study is currently available on the bioRxiv* preprint server.
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
More than half of men dying of prostate cancer use hospice care - a significant increase over the last two decades - but most wait too long to enroll so they can't take full advantage of the palliative care that could make their deaths easier, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center found.
› Verified 4 days ago
Dr. Josh Weng, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 624 W Duarte Rd, #106, Arcadia, CA 91007 Phone: 626-447-4483 Fax: 626-447-4482 | |
Dr. Loanne Bich Tran, M.D., MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 624 W Duarte Rd Ste 205, Arcadia, CA 91007 Phone: 626-446-0810 Fax: 626-254-9879 | |
Pai-hsiang Chen, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr, Suite 310, Arcadia, CA 91007 Phone: 626-446-2360 Fax: 626-446-2370 | |
Dr. Benjamin Thomas Stafford, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 612 W Duarte Rd, Suite 304, Arcadia, CA 91007 Phone: 626-446-4461 Fax: 626-445-0647 | |
Dr. James Yu Chang Shen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr, Arcadia, CA 91007 Phone: 626-218-9840 Fax: 626-218-9860 | |
Nirmal Kumar Banskota, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1015 N 1st Ave B, Arcadia, CA 91006 Phone: 626-446-0559 Fax: 626-446-0689 | |
Dr. Haig Manjikian, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 450 E Huntington Dr, Arcadia, CA 91006 Phone: 626-462-1844 |